(Press-News.org) PHILADELPHIA – Fifty years ago, British researcher John Gurdon demonstrated that genetic material from non-reproductive, or somatic, cells could be reprogrammed into an embryonic state when transferred into an egg. In 2006, Kyoto University researcher Shinya Yamanaka expanded on those findings by expressing four proteins in mouse somatic cells to rewind their genetic clocks, converting them into embryonic-like stem cells called induced pluripotent stem cells, or iPS cells.
In early October, Gurdon and Yamanaka were awarded the 2012 Nobel Prize in Physiology or Medicine for their discoveries. Now, thanks to some careful detective work by a team of scientists led by Kenneth Zaret, PhD, at the Perelman School of Medicine, University of Pennsylvania, researchers can better understand just how iPS cells form – and why the Yamanaka process is so inefficient, an important step to work out for regenerative medicine. Zaret is associate director of the Penn Institute for Regenerative Medicine and professor of Cell and Developmental Biology.
The findings, which appear in the Nov. 21 issue of the journal Cell, uncover cellular impediments to iPS cell development that, if overcome, could dramatically improve the efficiency and speed of iPS cell generation.
"These studies provide detailed insights into how reprogramming factors interact with the chromatin of differentiated cells and start them down the path toward becoming stem cells," said Susan Haynes, PhD, National Institute of General Medical Sciences, which partially funded the work. "Dr. Zaret's work also identified a major structural roadblock in the chromatin that the factors must overcome in order to bind DNA. This knowledge will help improve the efficiency of reprogramming, which is important for any future therapeutic applications."
Human iPS cells are generated by expressing four DNA-binding proteins – Oct4, Sox2, Klf4, and c-Myc (O, S, K, and M) – in human non-reproductive, or somatic cells, such as skin cells. These factors have generated intense interest in the stem cell and medical communities, not least because they offer the promise of embryonic stem cells with none of the messy ethical and moral dilemmas. Just as significantly, patient-specific iPS cells from individuals with genetic disorders can be used to study disease origin and to develop drugs for a range of conditions such as Huntington's and Parkinson's diseases.
Yet, the process of generating iPS cells is highly inefficient. It can take a month to fully reprogram somatic cells into iPS cells, and as few as one in 1,000 cells that take up the four factors will successfully convert. What's more, some studies indicate that, for all their plasticity, iPS cells are not precisely equivalent to embryonic stem cells. Zaret, with Penn postdoctoral fellow Abdenour Soufi, PhD, and bioinformatician Greg Donahue, PhD, decided to find out why.
Destination Determination
The team analyzed the destination in the human genome of the four reprogramming factors 48 hours after the initiation of iPS cell reprogramming and compared those locations to four cell types: the starting cell population; the fully reprogrammed iPS cells; cells nearing the end of the reprogramming process (pre-iPS); and embryonic stem cells.
They found that at 48 hours the factors tended to bind gene regulatory elements called enhancers, far removed from the genes they regulate, rather than the target genes themselves. That suggests that O, S, and K serve as "pioneer factors" that open closed chromatin structures on the DNA itself, facilitating the reprogramming process by making target sections of the genome available to be read by messenger RNA.
The team also found large regions of the genome that were "refractory" to the binding of reprogramming factors at 48 hours, but which were eventually activated in, and are in fact required, for the formation of iPS cells.
"Basically, large chunks of the human genome were physically resisting these factors from entering," Zaret explained. "That provided some understanding that you've got to overcome the binding impediment to get these factors to their final destination."
These refractory sequences tended to be chemically marked with a histone modification called H3K9me3. When the team blocked the enzymes that create that modification, they "significantly accelerated" the reprogramming process.
According to Zaret, these findings reveal genetic roadblocks that slow and impede the iPS cell reprogramming process, as well as factors that may underlie the subtle differences between iPS and embryonic stem cells. They also suggest a potential workaround to these issues, by adding inhibitors of H3K9me3.
But the findings also reveal a normal cellular mechanism that cells may be using to repress blocks of genes that are contrary to the cell's biology, Zaret said. "We went into this thinking we were going to learn something about the mechanism of conversion to pluripotency, but at the end of the day we ended up discovering new ways that cells control gene expression by shutting down parts of their genome."
INFORMATION:
The study was supported by the National Institute of General Medical Sciences (Grants R37GM36477 and P01GM099134).
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital — the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.
Penn study decodes molecular mechanisms underlying stem cell reprogramming
2012-11-15
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Early 50s may be key time to reach baby boomers with health messages
2012-11-15
COLUMBUS, Ohio -- For baby boomers, the peak interest in health issues comes at about age 51, with a second peak coming near age 65, according to a new study.
The results may help doctors and other professionals target this generation with health messages at a time when they are most receptive to hearing them, the researchers said.
The study, based on a survey of Americans age 45 to 65, showed that people in their late 40s had the lowest levels of interest in health issues. Interest rose quickly, however, and peaked in the early 50s, then dropped slightly and plateaued ...
Feinstein Institute researchers discover plant derivative
2012-11-15
MANHASSET, NY – Researchers at The Feinstein Institute for Medical Research have discovered that tanshinones, which come from the plant Danshen and are highly valued in Chinese traditional medicine, protect against the life-threatening condition sepsis. The findings are published in the December issue of Biochemical Pharmacology.
Inflammation is necessary for maintaining good health – without inflammation, wounds and infections would never heal. However, persistent and constant inflammation can damage tissue and organs, and lead to diseases such as sepsis. Sepsis affects ...
Researchers tap into CO2 storage potential of mine waste
2012-11-15
VANCOUVER, CANADA, NOVEMBER 15, 2012 -- It's time to economically value the greenhouse gas-trapping potential of mine waste and start making money from it, says mining engineer and geologist Michael Hitch of the University of British Columbia (UBC).
Hitch studies the value of mine waste rock for its CO2-sequestration potential, or "SP." He says mining companies across Canada will, in future, be able to offset CO2 emissions with so-named "SP rock," and within 25 years could even be selling emissions credits.
Digging, trucking and processing make mining an energy-intensive ...
Eating more fish could reduce postpartum depression
2012-11-15
Low levels of omega-3 may be behind postpartum depression, according to a review lead by Gabriel Shapiro of the University of Montreal and the Research Centre at the Sainte-Justine Mother and Child Hospital. Women are at the highest risk of depression during their childbearing years, and the birth of a child may trigger a depressive episode in vulnerable women. Postpartum depression is associated with diminished maternal health as well as developmental and health problems for her child. "The literature shows that there could be a link between pregnancy, omega-3 and the ...
Family commitment blended with strong religion dampens civic participation, Baylor researcher finds
2012-11-15
Blending religion with familism — a strong commitment to lifelong marriage and childbearing — dampens secular civic participation, according to research by a Baylor University sociologist.
"Strong family and strong religion. What happens when they meet? Is that good for the larger society? It is not always as it seems," said Young-Il Kim, Ph.D., Postdoctoral Fellow in Baylor's Institute for Studies of Religion.
His study — "Bonding alone: Familism, religion and secular civic participation" — is published online in Social Science Research. The findings are based on analysis ...
New study finds milk-drinking kids reap physical benefits later in life
2012-11-15
Starting a milk drinking habit as a child can lead to lifelong benefits, even improving physical ability and balance in older age, according to new research. A new study published in Age & Aging found an increase of about one glass of milk a day as a child was linked to a 5% faster walking time and 25% lesser chance of poor balance in older age. The researchers suggest a "public health benefit of childhood milk intake on physical function in old age" – a finding that has huge potential for adults over 65, a population expected reach more than 70 million by the year 2030, ...
How 'black swans' and 'perfect storms' become lame excuses for bad risk management
2012-11-15
The terms "black swan" and "perfect storm" have become part of public vocabulary for describing disasters ranging from the 2008 meltdown in the financial sector to the terrorist attacks of September 11. But according to Elisabeth Paté-Cornell, a Stanford professor of management science and engineering, people in government and industry are using these terms too liberally in the aftermath of a disaster as an excuse for poor planning.
Her research, published in the November issue of the journal Risk Analysis, suggests that other fields could borrow risk analysis strategies ...
A new way of looking at Prader-Willi Syndrome
2012-11-15
An Australian study reveals that people with the rare genetic disorder known as Prader-Willi Syndrome may have an impaired autonomic nervous system. This discovery opens up a new way of looking at the insatiable appetite experienced by all sufferers, as well as their very high risk of cardiovascular disease.
The autonomic nervous system controls our inner organs, including our gut, heart, liver and blood vessels. It is a finely tuned, dynamic system, responding moment-by-moment to the body's needs.
Researchers from Sydney's Garvan Institute of Medical Research, including ...
Scientists show protein-making machinery can switch gears with a small structural change process, which may have implications for immunity and cancer therapy, compared to the movie The Transformers
2012-11-15
JUPITER, FL, November 15, 2012 – For the past several years, Min Guo, an assistant professor at The Scripps Research Institute, has focused on the intricate actions of an ancient family of catalytic enzymes that play a key role in translation, the process of producing proteins.
These complex enzymes are a group of fundamental molecules that make building blocks for protein production. Present in every cell, these enzymes—known as aminoacyl-transfer RNA synthetases (tRNA synthetases)—select the proper amino acid and assign them to transfer RNAs to make a protein in the ...
Genetics point to serious pregnancy complication
2012-11-15
New research at the University of Adelaide has revealed a genetic link in pregnant mums - and their male partners - to pre-eclampsia, a life-threatening complication during pregnancy.
Pre-eclampsia involves high blood pressure and fluid retention and can cause damage to the kidneys and liver. About 7% of pregnancies are affected by pre-eclampsia.
In a paper now online in the journal Placenta ahead of print publication, the researchers say they have found a genetic variant involving the AGT2R gene, which may predispose women to pre-eclampsia.
However, the genetic variant ...